Sitetracker Launches Enhanced O&M Tools to Drive Efficiency Across the Asset Lifecycle
5.5.2025 15:00:00 CEST | Business Wire | Press release
Sitetracker, the global leader in complete Asset Lifecycle Management, today announced significant enhancements to its Operations and Maintenance (O&M) solution. These advancements reinforce Sitetracker's position as the leading end-to-end platform built to help asset owners and contractors plan, build, operate, and maintain critical infrastructure at scale.
As infrastructure networks grow more distributed and complex—driven by the accelerating energy transition, AI’s demand on energy and digital infrastructure, and global connectivity—operations and maintenance teams are under increasing pressure. Assets are often deployed in remote locations, teams are expected to do more with fewer resources, and the margin for error has never been slimmer. Success now depends on having intelligent, scalable tools that enable safe, efficient, and proactive asset management at every stage.
“Operations and maintenance are no longer back-office functions—they're front and center in ensuring ROI and reliability in critical infrastructure,” said Giuseppe Incitti, CEO of Sitetracker. “Our enhanced O&M solution ensures that our customers have the tools to maintain and protect the assets they’ve invested in, with intelligence, safety, and speed.”
To support operations and maintenance teams in their critical work, Sitetracker is introducing a suite of new capabilities designed to extend the value of its existing O&M solution:
- Boost flexibility and operational efficiency with a new job scheduler agent that allows for greater flexibility in assigning work, a smart scheduling agent, and improved mobile and web inventory workflows that make it easier to find and track parts when needed. Intelligent task grouping helps teams manage complex maintenance schedules and reduce unnecessary truckrolls.
- Take a safety-first approach by embedding critical safety protocols directly into field workflows, making them easily accessible. New features such as job safety analysis, automated site check-in/out, hazard alerts triggered by conditions ranging from severe weather to environmental risks like scorpions, real-time safety pings, and emergency notifications for lone workers help protect field teams and reduce risk.
- Maintain healthy sites with dynamic preventative maintenance tools that automate recurring service based on actual task completion—extending asset life, minimizing downtime, and avoiding costly repairs.
- Ensure high-quality work and first-time-fix with AI-powered computer vision—photo analysis that verifies field photos for quality and context at the source, improving proof-of-work processes and automating the inspection and review of photos.
- Track service performance and enforce accountability with robust SLA and contract management tools that tie directly to field workflows. Sitetracker tracks key metrics—including mean time to respond, mean time to repair, and both customer and contractor SLA compliance rates—empowering teams to make more informed, data-driven decisions about asset maintenance strategies.
- Deliver deeper asset intelligence and visibility through asset hierarchies, geospatial data, and enhanced reporting that connect lifecycle events—from installation date to maintenance schedules, costs, and warranties—empowering organizations to identify underperforming vendors and optimize long-term performance.
- Enhance overall operations with a full, asset-centric O&M solution that consolidates forms, safety, preventative and corrective maintenance, and inventory into one platform. Built to manage complexity at scale, Sitetracker supports both high volumes of sites and large volumes of assets within a site—standardizing processes through powerful templates and workflows, and driving increased field compliance and adoption through a redesigned, intuitive mobile experience.
“Leveraging Sitetracker's O&M capabilities has allowed our teams to drastically streamline operations and improve visibility across all types of work—whether proactive, reactive, or break-fix. With real-time insights, centralized scheduling, and deep integration into our financial systems, we’ve reduced cycle and billing times significantly.” — Dan Berman, CIO, Smartlink
“Using Sitetracker to manage the operations and maintenance of our entire charging estate has given us exceptional visibility and control. Our O&M project setup automatically creates jobs up to five years in advance from each charger’s commissioning date, allowing us to plan contractor schedules and forecast costs well ahead of time. We rely on Sitetracker’s ticketing system to handle all fault visits, which are seamlessly linked to jobs and integrated with our finance process. Sitetracker is an invaluable tool to help us grow and maintain our network.” — Sebastian Hymas, Head of Business Operations, Evyve
With Sitetracker, customers don’t just get best-in-class O&M—they get a fully connected asset lifecycle solution that improves handoffs between planning, construction, operations, and finance. This eliminates silos, ensures data continuity, and delivers a unified source of truth across the business. This means smarter decisions, faster execution, and stronger performance in the face of rising global infrastructure demands.
About Sitetracker
Sitetracker empowers owners, operators, contractors, and other stakeholders to streamline and optimize the end-to-end asset lifecycle of critical infrastructure. As the leading global complete Asset Lifecycle Management platform, Sitetracker helps innovative companies like Vodafone, Ericsson, ENGIE, Telefonica, Cypress Creek Renewables, Cox, Iberdrola, EVgo, Vantage Towers, Southern Company, Zayo, Tilson, Nextera, EDOTCO, E.On, Axione, and TEP efficiently plan, build, operate, and maintain millions of projects, sites, and assets. Sitetracker delivers operational excellence and creates full transparency across industries such as digital infrastructure, renewables, EV charging, utilities, and real estate by driving safe, efficient teams, ensuring healthy projects, and enabling organizations to manage scale, growth, and complexity. Trusted by hundreds of industry leaders, Sitetracker advances a more connected and sustainable future across the world. Manage What’s Critical, with Sitetracker.
For more information, please request a demo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250505624817/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom